Home > Insider Trading > Filing (0001567619-20-020982)

Filing Details

Accession Number:: 0001567619-20-020982
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2020-12-11 17:00:45
Reporting Period:: 2020-11-02

Accepted Time:: 2020-12-11 17:00:45
Original Submission Date:: 2020-11-04
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
874716	Idexx Laboratories Inc	IDXX	In Vitro & In Vivo Diagnostic Substances (2835)	010393723

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1184149	W Jonathan Ayers	One Idexx Drive Westbrook ME 04092		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2020-11-02	26,120	$424.82	737,347	No	4	F	Direct
Common Stock	Disposition	2020-11-02	2,725	$429.93	734,622	No	4	S	Direct
Common Stock	Disposition	2020-11-02	2,102	$430.72	732,520	No	4	S	Direct
Common Stock	Disposition	2020-11-02	500	$432.28	732,020	No	4	S	Direct
Common Stock	Disposition	2020-11-02	1,015	$433.42	731,005	No	4	S	Direct
Common Stock	Disposition	2020-11-02	1,285	$434.47	729,720	No	4	S	Direct
Common Stock	Disposition	2020-11-02	773	$435.53	728,947	No	4	S	Direct
Common Stock	Disposition	2020-11-02	300	$436.70	728,647	No	4	S	Direct
Common Stock	Disposition	2020-11-02	400	$438.54	728,247	No	4	S	Direct
Common Stock	Disposition	2020-11-02	800	$439.59	727,447	No	4	S	Direct
Common Stock	Disposition	2020-11-02	100	$440.23	727,347	No	4	S	Direct
Common Stock	Disposition	2020-11-03	134	$437.32	727,213	No	4	S	Direct
Common Stock	Disposition	2020-11-03	700	$439.56	726,513	No	4	S	Direct
Common Stock	Disposition	2020-11-03	400	$440.09	726,113	No	4	S	Direct
Common Stock	Disposition	2020-11-03	1,357	$442.14	724,756	No	4	S	Direct
Common Stock	Disposition	2020-11-03	3,622	$443.84	721,134	No	4	S	Direct
Common Stock	Disposition	2020-11-03	3,011	$444.69	718,123	No	4	S	Direct
Common Stock	Disposition	2020-11-03	908	$446.02	717,215	No	4	S	Direct
Common Stock	Disposition	2020-11-03	300	$446.98	716,915	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	10,000	Indirect	by Ayers Family Trust

Footnotes

Shares withheld for the payment of taxes on the conversion of 14,791 deferred stock units ('DSUs') acquired pursuant to the IDEXX Laboratories, Inc. Executive Deferred Compensation Plan and which were reported previously on Table I and represented a right to receive one share of Issuer common stock without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on November 7, 2007 and on June 15, 2015 (the "Stock Splits"). The total number of securities previously reported as beneficially owned, as adjusted to reflect the Stock Splits, is 59,164 DSUs, which were converted to an equal number of shares of Issuer common stock one year following the reporting person's resignation as an executive from IDEXX Laboratories, Inc.
Represents the weighted average price of the shares sold ranging from a low of $429.39 to a high of $430.375 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $430.42 to a high of $431.28 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $431.815 to a high of $432.72 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $432.96 to a high of $433.96 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $433.99 to a high of $434.88 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $435.17 to a high of $436.10 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $436.18 to a high of $437.04 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $438.01 to a high of $439.00 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $439.045 to a high of $439.83 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $439.029 to a high of $439.77 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $441.89 to a high of $442.77 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $443.17 to a high of $444.10 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $444.35 to a high of $445.27 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $445.46 to a high of $446.31 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $446.74 to a high of $447.10 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.